U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849752) titled 'Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF' on April 20, 2024.
Brief Summary: EAGLE-HF (Early Assessment and initiation of GuideLine-directed Evidence-based management-HF) is a prospective single site study of a multinational, unblinded, randomized-controlled, longitudinal trial called SYMPHONY. Primary, secondary and exploratory outcomes that are part of SYMPHONY are not described herein as they replicate SYMPHONY outcomes. Data associated with SYMPHONY outcomes will be sent to the SYMPHONY coordinating center. In EAGLE-HF, site investigators will examine if a new-onset heart failure (HF) dia...